The board-certified specialists leading the Lung Cancer Center in Philadelphia have combined expertise in delivering state-of-the-art diagnostics and treatments for lung cancer patients. Shayma Kazmi, MD, RPh, who is board certified in internal medicine and medical oncology and hematology, is an American Lung Association board member with a years of experience in conducting clinical trials at CTCA®. Sharing a leadership role at our Lung Cancer Center is Emil Abramian, MD, a fellowship-trained Interventional Pulmonologist and Critical Care physician and associate professor at Drexel University Hospital. Together, these doctors and the center’s other clinicians collaborate daily in providing comprehensive, individualized diagnosis and treatment options to lung cancer patients, monitoring their progress throughout treatment and making adjustments when necessary along the way.
Read more about these doctors and the rest of the Lung Cancer Center team below.